Skip to main content
OpenTrials

Clinical trial condition

Malformations of Cortical Development, Group I

Explore clinical trials studying Malformations of Cortical Development, Group I. Study availability and eligibility vary by location and protocol.

123 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Malformations of Cortical Development, Group I trial results

Completed

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

NCT02849457

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 13 locations
View Trial Details
Completed

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

NCT01906866

Conditions
Abnormalities, Multiple, Angelman Syndrome, Autism Spectrum Disorder, +30 more
Locations
  • Southwest Autism Research and Resource Center (SARRC) Phoenix, Arizona, United States
  • Crystal BioMedical Research, LLC Miami Lakes, Florida, United States
  • Lake Mary Pediatrics Orange City, Florida, United States
  • Mate Lazlo West Palm Beach, Florida, United States
View all 28 locations
View Trial Details
Completed

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

NCT03826628

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facial Angiofibroma, +13 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • All Children's Research Institute St. Petersburg, Florida, United States
  • Spectrum Health Grand Rapids, Michigan, United States
View all 17 locations
View Trial Details
Completed

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)

NCT04285346

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations
  • Marinus Research Site Los Angeles, California, United States
  • Marinus Research Site Palo Alto, California, United States
  • Marinus Research Site Boston, Massachusetts, United States
  • Marinus Research Site Livingston, New Jersey, United States
View Trial Details

Related conditions